Most people know someone who has tried antidepressants. For some, the right pill is a quiet turning point. For others, it is a long and frustrating hunt through doses and side effects that lead nowhere.
New research from the University of Helsinki points to a reason. A brain scan study published in Nature Mental Health found that depression splits into five distinct profiles, each with its own pattern of brain activity and its own cluster of symptoms.
The team used magnetoencephalography, called MEG, a scanner that reads the tiny magnetic fields given off by electrical activity in the brain. They scanned 263 adults with major depression and 75 healthy adults for comparison.
The five profiles behind one diagnosis
Two profiles sat at opposite ends. One group showed unusually strong connections between brain regions along with severe depression, anxiety, and heavy rumination. Another had weak connections and milder symptoms.
A third profile had broadly weak connectivity and strong signs of post-traumatic stress disorder. A fourth, mixed pattern paired severe depression with substance abuse and poor well-being.
A fifth group had the strongest connections of all. It was tied to pronounced substance abuse but fewer trauma symptoms.
What the brain patterns say about treatment
According to Satu Palva, Director of the Neuroscience Center at the University of Helsinki, the scanner lets researchers watch brain activity in real time.
"MEG enabled us to monitor electrical brain activity with millisecond precision, helping us get closer to what actually happens in the brain at any given moment," she said.
Also read: 8 bowel cancer warning signs that get blamed on IBS, hemorrhoids or stress
That precision is why five patterns emerged where a standard interview sees one condition. The idea is not to replace a doctor's diagnosis but to add a layer of biology under it.
Treatments could then be matched to a patient's brain pattern instead of chosen through trial and error. The Helsinki team cautions that the technology is not ready for the clinic.
What this means for patients today
Depression affects an estimated 280 million people worldwide, according to the World Health Organization. Yet psychiatry still has no scan or blood test that says which treatment will work.
If you are struggling to find a treatment that works, the standard path has not changed. Talk to your doctor about adjusting the dose, switching medications, or adding therapy. MEG scans for depression are not available as a clinical test.
Also read: Why mosquitoes keep picking you: A skin oil compound may give you away
Also read: 8 bed bug warning signs
This article is made and published by Aksel Kryhlmand, who may have used AI in the preparation.